Phase III Multi-Centre Open-Label Randomized Controlled Trial of Selective Internal Radiation Therapy (SIRT) Versus Sorafenib in Locally Advanced Hepatocellular Carcinoma.

Status: Active, no longer recruiting

Phase of Trial: Phase III

Latest Information Update: 08 Nov 2021

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

22 Apr 2018 Planned End Date changed from 1 Dec 2017 to 31 Jul 2018.
22 Apr 2018 Planned primary completion date changed from 1 Dec 2017 to 31 Jul 2018.
02 Mar 2018 Primary endpoint has not been met. (Overall Survival) as per results published in the Journal of Clinical Oncology

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com